Bisphosphonate use and hip fracture epidemiology: ecologic proof from the contrary.
about
Anti-osteoporosis drug prescribing after hip fracture in the UK: 2000-2010Histomorphometry of the organic matrix of the femur in ovariectomized rats treated with sodium alendronate.Demographic factors in hip fracture incidence and mortality rates in California, 2000-2011.Hip fracture incidence in Japan: Estimates of new patients in 2012 and 25-year trendsUnchanging incidence of hip fracture in southeastern norway.Anti-Osteoporosis Medication Prescriptions and Incidence of Subsequent Fracture Among Primary Hip Fracture Patients in England and Wales: An Interrupted Time-Series Analysis.Trends in and relation between hip fracture incidence and osteoporosis medication utilization and prices in Estonia in 2004-2015.Addressing the Crisis in the Treatment of Osteoporosis: A Path Forward.Age-period-cohort effects in the incidence of hip fractures: political and economic events are coincident with changes in risk.Trends in Media Reports, Oral Bisphosphonate Prescriptions, and Hip Fractures 1996-2012: An Ecological Analysis.Trends in hip fracture incidence and in the prescription of antiosteoporosis medications during the same time period in Belgium (2000-2007).Hip fracture rates and bisphosphonate consumption in Spain. An ecologic study.A population-based analysis of the post-fracture care gap 1996-2008: the situation is not improving.Effectiveness of elcatonin for alleviating pain and inhibiting bone resorption in patients with osteoporotic vertebral fractures.
P2860
Q35789242-3F62EF4E-220C-43F9-BD28-25A7B7C9303CQ35901725-CAFCA11A-A436-4143-AC2E-61FC4F26DB2DQ36443177-AED20090-AF91-4984-B56D-4C92277F98F0Q36918421-14420F2C-9BE3-48FD-B1C9-2F76C393B7CBQ37212799-AFEC37A0-151F-4F94-BAF8-AE26CDCEAC34Q37437745-AE3AB87C-A3E8-40A8-8902-ACB6034AB36EQ38790108-FEFD98BA-7F69-4E52-90FF-BDDE8616B096Q39014377-4C087BFE-2FC0-4C6D-ABB8-BF9340B020CDQ39360356-BB531494-2F45-4EB9-87C5-EAC5C80DCA89Q40896162-C4628683-D0C0-407A-B6D4-293A9F2163A8Q44097503-D864FE75-95F9-4089-8555-F5653337704FQ46170469-73351B2C-1C87-4007-9FBC-4F83E8E305FAQ46733042-C8FB5D79-B761-4257-B123-FFACAFA9D478Q47951133-C61BC5D4-104A-4D9D-904B-D6BA5EBDFB79
P2860
Bisphosphonate use and hip fracture epidemiology: ecologic proof from the contrary.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Bisphosphonate use and hip fracture epidemiology: ecologic proof from the contrary.
@ast
Bisphosphonate use and hip fracture epidemiology: ecologic proof from the contrary.
@en
Bisphosphonate use and hip fracture epidemiology: ecologic proof from the contrary.
@nl
type
label
Bisphosphonate use and hip fracture epidemiology: ecologic proof from the contrary.
@ast
Bisphosphonate use and hip fracture epidemiology: ecologic proof from the contrary.
@en
Bisphosphonate use and hip fracture epidemiology: ecologic proof from the contrary.
@nl
prefLabel
Bisphosphonate use and hip fracture epidemiology: ecologic proof from the contrary.
@ast
Bisphosphonate use and hip fracture epidemiology: ecologic proof from the contrary.
@en
Bisphosphonate use and hip fracture epidemiology: ecologic proof from the contrary.
@nl
P2093
P2860
P356
P1476
Bisphosphonate use and hip fracture epidemiology: ecologic proof from the contrary.
@en
P2093
Alex Fisher
Jodie Martin
Michael Davis
Wichat Srikusalanukul
P2860
P304
P356
10.2147/CIA.S13909
P407
P577
2010-11-19T00:00:00Z